These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA. Sugiyama H; Yoshida I; Ueki M; Tanabe K; Manaka A; Hiramatsu K J Antibiot (Tokyo); 2017 Mar; 70(3):264-271. PubMed ID: 28074049 [TBL] [Abstract][Full Text] [Related]
24. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. Malbruny B; Nagai K; Coquemont M; Bozdogan B; Andrasevic AT; Hupkova H; Leclercq R; Appelbaum PC J Antimicrob Chemother; 2002 Jun; 49(6):935-9. PubMed ID: 12039885 [TBL] [Abstract][Full Text] [Related]
25. 23S rRNA gene mutations contributing to macrolide resistance in Campylobacter jejuni and Campylobacter coli. Ladely SR; Meinersmann RJ; Englen MD; Fedorka-Cray PJ; Harrison MA Foodborne Pathog Dis; 2009; 6(1):91-8. PubMed ID: 19014274 [TBL] [Abstract][Full Text] [Related]
26. [Association between MLS antibiotic and tetracycline resistance genes in Streptococcus pneumoniae]. Seral C; Castillo FJ; Rubio-Calvo MC; García C; Gómez-Lus R Rev Esp Quimioter; 2001 Mar; 14(1):55-62. PubMed ID: 11376351 [TBL] [Abstract][Full Text] [Related]
27. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. Mazzariol A; Koncan R; Vitali LA; Cornaglia G J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779 [TBL] [Abstract][Full Text] [Related]
28. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828 [TBL] [Abstract][Full Text] [Related]
29. Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. Arthur M; Brisson-Noël A; Courvalin P J Antimicrob Chemother; 1987 Dec; 20(6):783-802. PubMed ID: 3326871 [TBL] [Abstract][Full Text] [Related]
30. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Giovanetti E; Montanari MP; Mingoia M; Varaldo PE Antimicrob Agents Chemother; 1999 Aug; 43(8):1935-40. PubMed ID: 10428916 [TBL] [Abstract][Full Text] [Related]
31. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Depardieu F; Courvalin P Antimicrob Agents Chemother; 2001 Jan; 45(1):319-23. PubMed ID: 11120988 [TBL] [Abstract][Full Text] [Related]
32. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Sutcliffe J; Tait-Kamradt A; Wondrack L Antimicrob Agents Chemother; 1996 Aug; 40(8):1817-24. PubMed ID: 8843287 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America. Hoban DJ J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558 [TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Reinert RR; Reinert S; van der Linden M; Cil MY; Al-Lahham A; Appelbaum P Antimicrob Agents Chemother; 2005 Jul; 49(7):2903-13. PubMed ID: 15980367 [TBL] [Abstract][Full Text] [Related]
35. Mobile elements and chromosomal changes associated with MLS resistance phenotypes of invasive pneumococci recovered in the United States. Hawkins PA; Chochua S; Jackson D; Beall B; McGee L Microb Drug Resist; 2015 Apr; 21(2):121-9. PubMed ID: 25115711 [TBL] [Abstract][Full Text] [Related]
36. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Pereyre S; Guyot C; Renaudin H; Charron A; Bébéar C; Bébéar CM Antimicrob Agents Chemother; 2004 Feb; 48(2):460-5. PubMed ID: 14742195 [TBL] [Abstract][Full Text] [Related]
37. 23S rRNA and L22 ribosomal protein are involved in the acquisition of macrolide and lincosamide resistance in Mycoplasma capricolum subsp. capricolum. Prats-van der Ham M; Tatay-Dualde J; Gómez-Martín Á; Corrales JC; Contreras A; Sánchez A; de la Fe C Vet Microbiol; 2018 Mar; 216():207-211. PubMed ID: 29519518 [TBL] [Abstract][Full Text] [Related]
38. [Beta-lactam and macrolide resistance in Streptococcus pneumoniae]. Shibasaki Y; Ubukata K Nihon Rinsho; 2001 Apr; 59(4):681-6. PubMed ID: 11304989 [TBL] [Abstract][Full Text] [Related]
39. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations. Farrell DJ; Morrissey I; Bakker S; Buckridge S; Felmingham D Antimicrob Agents Chemother; 2004 Aug; 48(8):3169-71. PubMed ID: 15273142 [TBL] [Abstract][Full Text] [Related]
40. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci]. Bejuk D Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]